Navigate to
-
Over time, technology has significantly contributed to health care advancements. Some of these enhancements are now considered routine components of care and include electronic health record,...
-
For the first time, Prime Therapeutics hosted the AMCP Nexus specialty keynote, addressing trends in cell and gene therapy and rare disease and immunology categories
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Warning:You do not have the permission to access the upload fields on this form. Contact the form owner or portal administrator to request the access. Pharmacy/Provider Warning:You do not have the...
-
Nicole Grevenitz, director of clinical account services, shares more from the research study “Promoting Health Equity Through Enhanced, Personalized Digital Outreach.”
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
With an established playbook for launching new union business, we ensure smooth transitions, clear communication and rapid implementation. Our Special Investigations Unit (SIU) uses advanced...
-
Prime’s Sean Wuest and Highmark Health’s Lisanne Holley present educational session at Last Vegas event
Prime Article: Perspectives -
Prime's Sneha Sharma and Michael Szatkowski present “A beginner’s guide to decoding cell and gene therapy” educational session at event in Las Vegas, Nevada
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Lead author Kristin Brown-Gentry shares insights from the study “Unlocking Public Health Insights: Leveraging Air Quality Data to Develop Social Determinants of Health Metrics Linked to Asthma...
Prime Article: Perspectives -
Nick Friedlander, clinical program pharmacist at Prime, shares more about two research studies that convey the impact of one cost-savings solution.
PA Sub-Categories: Products Specialty drugs Prime Article: Perspectives -
Brooke Hunter, senior health outcomes scientist at Prime, shares more about the study “Methodological Framework for Propensity Adjusted Benchmarks for Pharmacy Key Performance Indicators”
Prime Article: Perspectives